Structure

InChI Key NNACHAUCXXVJSP-UHFFFAOYSA-N
Smile Clc1ccc(CCCOCCCN2CCCCC2)cc1
InChI
InChI=1S/C17H26ClNO/c18-17-9-7-16(8-10-17)6-4-14-20-15-5-13-19-11-2-1-3-12-19/h7-10H,1-6,11-15H2

Physicochemical Descriptors

Property Name Value
Molecular Formula C17H26ClNO
Molecular Weight 295.85
AlogP 4.17
Hydrogen Bond Acceptor 2.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 8.0
Polar Surface Area 12.47
Molecular species BASE
Aromatic Rings 1.0
Heavy Atoms 20.0

Pharmacology

Action Mechanism of Action Reference
INVERSE AGONIST Histamine H3 receptor inverse agonist PubMed PubMed
Primary Target
H3 receptor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Narcolepsy 3 D009290 ClinicalTrials
Parkinson Disease 3 D010300 ClinicalTrials
Narcolepsy 3 D009290 ClinicalTrials
Prader-Willi Syndrome 2 D011218 ClinicalTrials
Schizophrenia 2 D012559 ClinicalTrials
Alcoholism 2 D000437 ClinicalTrials
Kidney Diseases 1 D007674 ClinicalTrials
Substance-Related Disorders 1 D019966 ClinicalTrials

Related Entries

Scaffolds

Salt

Cross References

Resources Reference
CAS NUMBER 362665-56-3
ChEBI 134709
ChEMBL CHEMBL462605
DrugBank DB11642
DrugCentral 5048
FDA SRS 4BC83L4PIY
Guide to Pharmacology 8924
PubChem 9948102
SureChEMBL SCHEMBL117648
ZINC ZINC000034045468